Exodus Point Capital Management, LP Supernus Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

  • $16.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
BUY
$34.93 - $42.03 $1.66 Million - $1.99 Million
47,421 New
47,421 $1.72 Million
Q2 2022

Aug 19, 2022
SELL
$25.33 - $34.25 $844,578 - $1.14 Million
-33,343 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$28.51 - $32.9 $72,044 - $83,138
-2,527 Reduced 7.04%
33,343 $1.08 Million
Q4 2021

Feb 11, 2022
BUY
$26.37 - $34.22 $945,891 - $1.23 Million
35,870 New
35,870 $1.05 Million

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email